[go: up one dir, main page]

BE787901A - ANTIVARIOLIC VACCINE - Google Patents

ANTIVARIOLIC VACCINE

Info

Publication number
BE787901A
BE787901A BE787901A BE787901A BE787901A BE 787901 A BE787901 A BE 787901A BE 787901 A BE787901 A BE 787901A BE 787901 A BE787901 A BE 787901A BE 787901 A BE787901 A BE 787901A
Authority
BE
Belgium
Prior art keywords
antivariolic
vaccine
antivariolic vaccine
Prior art date
Application number
BE787901A
Other languages
French (fr)
Inventor
A H Stickl
Original Assignee
Freistaat Bayern Represente Pa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712145477 external-priority patent/DE2145477C3/en
Application filed by Freistaat Bayern Represente Pa filed Critical Freistaat Bayern Represente Pa
Publication of BE787901A publication Critical patent/BE787901A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE787901A 1971-09-11 1972-08-23 ANTIVARIOLIC VACCINE BE787901A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712145477 DE2145477C3 (en) 1971-09-11 Vaccine for intracutaneous smallpox vaccination

Publications (1)

Publication Number Publication Date
BE787901A true BE787901A (en) 1972-12-18

Family

ID=5819271

Family Applications (1)

Application Number Title Priority Date Filing Date
BE787901A BE787901A (en) 1971-09-11 1972-08-23 ANTIVARIOLIC VACCINE

Country Status (5)

Country Link
AT (1) AT320149B (en)
BE (1) BE787901A (en)
CH (1) CH568392A5 (en)
DK (1) DK137392C (en)
ES (1) ES406590A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (en) * 1977-04-01 1978-10-05 Mayr Anton PREPARATION FOR TREATING HERPES ZOSTER AND OTHER HERPES INFECTIONS AND METHOD FOR THE PRODUCTION THEREOF
JPS60202827A (en) * 1984-03-28 1985-10-14 Chibaken Attenuated variola vaccine strain
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
CA2489301A1 (en) 2002-08-07 2004-02-19 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of avipoxviruses
EP1610816B1 (en) 2003-03-28 2013-01-02 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Mva virus expressing modified hiv envelope, gag, and pol genes
EP2319860A3 (en) 2004-08-27 2011-06-15 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes
EP3988651A1 (en) 2007-05-14 2022-04-27 Bavarian Nordic A/S Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
MX2012002531A (en) 2009-10-08 2012-04-11 Bavarian Nordic As Generation of a broad t-cell response in humans against hiv.
JP5945270B2 (en) 2010-07-20 2016-07-05 バヴァリアン・ノルディック・アクティーゼルスカブ Method for collecting expression products
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
DE102013004595A1 (en) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV vaccines
CN109071592B (en) 2016-01-08 2022-07-19 吉奥瓦科斯公司 Compositions and methods for generating an immune response to a tumor-associated antigen
AU2020384323A1 (en) 2019-11-14 2022-06-02 Aelix Therapeutics, S.L. Dosage regimens for vaccines
WO2021260065A1 (en) 2020-06-24 2021-12-30 Consejo Superior De Investigaciones Científicas (Csic) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP3928789A1 (en) 2020-06-24 2021-12-29 Consejo Superior de Investigaciones Científicas (CSIC) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP4358999A1 (en) 2021-06-23 2024-05-01 Consejo Superior De Investigaciones Científicas Mva-based vaccine expressing a prefusion-stabilized sars-cov-2 s protein
EP4108257A1 (en) 2021-06-23 2022-12-28 Consejo Superior De Investigaciones Científicas Mva-based vaccine against covid-19 expressing a prefusion-stabilized sars-cov-2 s protein

Also Published As

Publication number Publication date
CH568392A5 (en) 1975-10-31
DK137392B (en) 1978-02-27
DK137392C (en) 1978-09-18
ES406590A1 (en) 1975-09-16
AT320149B (en) 1975-01-27
DE2145477A1 (en) 1973-03-15
DE2145477B2 (en) 1976-04-01

Similar Documents

Publication Publication Date Title
SE389206B (en) MEDICAL SETTING DEVICE
BE787901A (en) ANTIVARIOLIC VACCINE
IT973049B (en) FORMING DEVICE
BR7201651D0 (en) DENTAL UNIT
BE786707A (en) MITRAILLE PREPARATION
IT950664B (en) RADIOGONIOMETRIC PROCEDURE
FI53686C (en) AVTAPPNINGSPIP MED LUFTPASSAGE
SE398198B (en) PHARMACEUTICAL DEVICE
DK143912C (en) DOSAGE UNIT
DK132563C (en) SPREAD DEBLE
BE794307A (en) ANTI-CARIES VACCINE
BE792261A (en) HAIR PREPARATION
AT315658B (en) Spike
SE383083B (en) SYNCHRONIZATION DEVICE
BE790036A (en) AMBULANCE
SE380972B (en) DENTAL UNIT
IT966747B (en) PROCEDURE FOR PREPARING DINITROANTHRACHINONES
BE754523A (en) VACCINES
TR17350A (en) 6-HIDROXI-DIHIDRO-URASILLERIN IMALINE MAHSUS PROCEDURE
AT322091B (en) VACCINE
IT975399B (en) THERAPEUTIC DEVICE
ZA715544B (en) Vaccine preparation
FI56454B (en) FOER TVAOPUNKTSREGLERING AVSEDD STEGREGULATOR MED KOPPLINGSSTEG
BE767285A (en) DETERSION ADJUVANTS
IT956377B (en) DENTAL CHAIR